This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ogata, M Articles by Mizuguchi, Y Search for Related Content PubMed PubMed Citation Articles by Ogata, M Articles by Mizuguchi, Y

 Previous Article  |  Next Article 

Infect Immun. 1991 February; 59(2): 679-683

Enhancement of lipopolysaccharide-induced tumor necrosis factor production in mice by carrageenan pretreatment.

Department of Anesthesiology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.

ABSTRACT

Tumor necrosis factor (TNF) is a cytokine which mediates endotoxin shock and causes multiple organ damage. It is thought that macrophage (MP) activation is necessary to increase lipopolysaccharide (LPS)-induced TNF production and lethality. Carrageenan (CAR) is sulfated polygalactose which destroys MP; it is used as a MP blocker. We found that CAR pretreatment can increase both endotoxin-induced TNF production and the mortality rate in mice. The ddY mice (7 to 8 weeks old) were injected intraperitoneally with CAR (5-mg dose) and challenged intravenously with LPS 24 h later. Without CAR pretreatment, LPS doses of less than 10 micrograms did not induce TNF in sera. After pretreatment, however, about 3 x 10(3) to 4 x 10(4) U of TNF per ml was produced after LPS injection at doses of 0.1 to 10 micrograms, respectively. TNF production was significantly increased by CAR pretreatment at LPS doses of more than 10 micrograms. CAR pretreatment rendered the mice more sensitive to the lethal effect of LPS; 50% lethal doses of LPS in CAR-pretreated mice and nonpretreated mice were 26.9 and 227 micrograms, respectively. The mortality of the two groups was significantly different at doses of 50, 100, and 200 micrograms of LPS. CAR increased LPS-induced TNF production and mortality within 2 h, much earlier than MP activators, which needed at least 4 days. Our results made clear that TNF production is enhanced not only by a MP activator but also by a MP blocker.

This article has been cited by other articles:

• Beloeil, H., Asehnoune, K., Moine, P., Benhamou, D., Mazoit, J.-X. (2005). Bupivacaine's Action on the Carrageenan-Induced Inflammatory Response in Mice: Cytokine Production by Leukocytes After Ex-Vivo Stimulation. Anesth. Analg. 100: 1081-1086 [Abstract] [Full Text]  
• Donnelly, E. T., Bardwell, H., Thomas, G. A., Williams, E. D., Hoper, M., Crowe, P., McCluggage, W. G., Stevenson, M., Phillips, D. H., Hewer, A., Osborne, M. R., Campbell, F. C. (2004). Modulation of N-methyl-N-nitrosourea-induced crypt restricted metallothionein immunopositivity in mouse colon by a non-genotoxic diet-related chemical. Carcinogenesis 25: 847-855 [Abstract] [Full Text]  
• Ogata, M., Matsui, T., Kita, T., Shigematsu, A. (1999). Carrageenan Primes Leukocytes To Enhance Lipopolysaccharide-Induced Tumor Necrosis Factor Alpha Production. Infect. Immun. 67: 3284-3289 [Abstract] [Full Text]  
• Liang, A.H., Ohno, N., Yadomae, T. (1997). Inhibition of antibiotic-induced lysis and lipopolysaccharide release from Escherichia coli 0111 :B4 by egg white lysozyme. Innate Immunity 4: 105-114 [Abstract]  
• Takada, K., Ohno, N., Yadomae, T. (1995). Physicochemical and biological characterizations of complex formation between lipopolysaccharide and lysozyme. Innate Immunity 2: 255-262 [Abstract]